| Drug Name: | Dyclonine (586-60-7) |
|---|---|
| PubChem ID: | 3180 |
| SMILES: | CCCCOC1=CC=C(C=C1)C(=O)CCN2CCCCC2 |
| InchiKey: | BZEWSEKUUPWQDQ-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 289.419 |
| LogP | : | 3.9242 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 3 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 29.54 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Diabetic Eye Disease | Neuropeptide S receptor (Q6W5P4) | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
| Somnolence | 5-hydroxytryptamine receptor 2B (P41595) | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|